FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2310255737> ?p ?o ?g. }

• W2310255737 endingPage "1275" @default.
• W2310255737 startingPage "1270" @default.
• W2310255737 abstract "Information describing the efficacy and safety of infliximab (IFX) for Crohn's disease (CD) in China is limited. The aim of this study was to report response rates, relapse rates after IFX-induced remission, and adverse events, and identify factors associated with relapse in a cohort of CD patients treated with IFX in a Chinese center.Clinical data of CD patients treated with two or more infusions of IFX from July 2010 to February 2013 at Nanfang Hospital (Guangzhou, China) were retrieved and analyzed retrospectively. Primary measurements were clinical response rate and relapse rate during 30 weeks of follow-up. Overall adverse events and risk factors related to IFX were evaluated.A total of 70 CD patients were finally included. The clinical response rate was 98.6% at week 2, 97% at week 6, 92.5% at week 14, 84.9% at week 22, and 84.1% at week 30. The remission rate was 55.7% at week 2, 94% at week 6, 92.5% at week 14, 82.7% at week 22, and 77.3% at week 30. Relapse began following the third infusion. The relapse rate was 3.23% at week 6, 6.12% at week 14, 10.53% at week 22, and 8.82% at week 30. Adverse events related to IFX occurred in 32.6% of patients; most were mild and transient. Univariate analysis showed that sex was a significant predictor of clinical relapse.IFX is an effective and safe treatment for CD in Chinese patients. Sex may be an independent predictor of relapse." @default.
• W2310255737 created "2016-06-24" @default.
• W2310255737 creator A5002738306 @default.
• W2310255737 creator A5026060144 @default.
• W2310255737 creator A5033020983 @default.
• W2310255737 creator A5049645189 @default.
• W2310255737 creator A5067047813 @default.
• W2310255737 creator A5074754372 @default.
• W2310255737 creator A5083944564 @default.
• W2310255737 creator A5088174174 @default.
• W2310255737 date "2015-11-01" @default.
• W2310255737 modified "2023-09-27" @default.
• W2310255737 title "Infliximab for the treatment of Crohn’s disease" @default.
• W2310255737 cites W1547383859 @default.
• W2310255737 cites W1971331540 @default.
• W2310255737 cites W1971685694 @default.
• W2310255737 cites W1986382260 @default.
• W2310255737 cites W2009244545 @default.
• W2310255737 cites W2013407385 @default.
• W2310255737 cites W2016321388 @default.
• W2310255737 cites W2024162533 @default.
• W2310255737 cites W2026116536 @default.
• W2310255737 cites W2026437676 @default.
• W2310255737 cites W2054184323 @default.
• W2310255737 cites W2063115128 @default.
• W2310255737 cites W2069644264 @default.
• W2310255737 cites W2081135977 @default.
• W2310255737 cites W2083065071 @default.
• W2310255737 cites W2088034696 @default.
• W2310255737 cites W2088513474 @default.
• W2310255737 cites W2090638706 @default.
• W2310255737 cites W2094230091 @default.
• W2310255737 cites W2094385084 @default.
• W2310255737 cites W2097979070 @default.
• W2310255737 cites W2102013054 @default.
• W2310255737 cites W2117068106 @default.
• W2310255737 cites W2144550346 @default.
• W2310255737 cites W2145296408 @default.
• W2310255737 cites W2161452915 @default.
• W2310255737 cites W2171341132 @default.
• W2310255737 cites W2321453230 @default.
• W2310255737 cites W2326330820 @default.
• W2310255737 cites W2402574446 @default.
• W2310255737 cites W2510350041 @default.
• W2310255737 doi "https://doi.org/10.1097/meg.0000000000000447" @default.
• W2310255737 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26275085" @default.
• W2310255737 hasPublicationYear "2015" @default.
• W2310255737 type Work @default.
• W2310255737 sameAs 2310255737 @default.
• W2310255737 citedByCount "5" @default.
• W2310255737 countsByYear W23102557372016 @default.
• W2310255737 countsByYear W23102557372018 @default.
• W2310255737 countsByYear W23102557372019 @default.
• W2310255737 countsByYear W23102557372023 @default.
• W2310255737 crossrefType "journal-article" @default.
• W2310255737 hasAuthorship W2310255737A5002738306 @default.
• W2310255737 hasAuthorship W2310255737A5026060144 @default.
• W2310255737 hasAuthorship W2310255737A5033020983 @default.
• W2310255737 hasAuthorship W2310255737A5049645189 @default.
• W2310255737 hasAuthorship W2310255737A5067047813 @default.
• W2310255737 hasAuthorship W2310255737A5074754372 @default.
• W2310255737 hasAuthorship W2310255737A5083944564 @default.
• W2310255737 hasAuthorship W2310255737A5088174174 @default.
• W2310255737 hasConcept C126322002 @default.
• W2310255737 hasConcept C144301174 @default.
• W2310255737 hasConcept C167135981 @default.
• W2310255737 hasConcept C197934379 @default.
• W2310255737 hasConcept C2777138892 @default.
• W2310255737 hasConcept C2778715236 @default.
• W2310255737 hasConcept C2779134260 @default.
• W2310255737 hasConcept C2779280984 @default.
• W2310255737 hasConcept C38180746 @default.
• W2310255737 hasConcept C71924100 @default.
• W2310255737 hasConcept C72563966 @default.
• W2310255737 hasConcept C90924648 @default.
• W2310255737 hasConceptScore W2310255737C126322002 @default.
• W2310255737 hasConceptScore W2310255737C144301174 @default.
• W2310255737 hasConceptScore W2310255737C167135981 @default.
• W2310255737 hasConceptScore W2310255737C197934379 @default.
• W2310255737 hasConceptScore W2310255737C2777138892 @default.
• W2310255737 hasConceptScore W2310255737C2778715236 @default.
• W2310255737 hasConceptScore W2310255737C2779134260 @default.
• W2310255737 hasConceptScore W2310255737C2779280984 @default.
• W2310255737 hasConceptScore W2310255737C38180746 @default.
• W2310255737 hasConceptScore W2310255737C71924100 @default.
• W2310255737 hasConceptScore W2310255737C72563966 @default.
• W2310255737 hasConceptScore W2310255737C90924648 @default.
• W2310255737 hasIssue "11" @default.
• W2310255737 hasLocation W23102557371 @default.
• W2310255737 hasLocation W23102557372 @default.
• W2310255737 hasOpenAccess W2310255737 @default.
• W2310255737 hasPrimaryLocation W23102557371 @default.
• W2310255737 hasRelatedWork W1726928670 @default.
• W2310255737 hasRelatedWork W1963997208 @default.
• W2310255737 hasRelatedWork W2003561232 @default.
• W2310255737 hasRelatedWork W2049682478 @default.
• W2310255737 hasRelatedWork W2058060946 @default.
• W2310255737 hasRelatedWork W2065414773 @default.

• next